Mr. Shawah is a co-founder of Acurx Pharmaceuticals and has served as its Chief Financial Officer since June 2021, having previously served as the company's Chief Accounting Officer and Vice President of Finance from February 2018 to June 2021. Earlier he was Chief Accounting Officer of Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX) from 2014 until its April 2017 sale to PLx Pharma. He has also served as Vice President of Baldwin Pearson & Co., Inc., a commercial real estate firm, and as a director of Ameri100, a software integration company. Mr. Shawah, a certified public accountant, graduated from Bucknell University with a B.S. in Business Administration with a concentration in Accounting.